Efficacy News and Research

RSS
Estimating the risk of airborne SARS-CoV-2 transmission in a train carriage

Estimating the risk of airborne SARS-CoV-2 transmission in a train carriage

Piceatannol and mTOR inhibitor combination proves be an attractive therapeutic strategy for gastric cancer

Piceatannol and mTOR inhibitor combination proves be an attractive therapeutic strategy for gastric cancer

New EULAR task force aims to help achieve gender equity in academic rheumatology

New EULAR task force aims to help achieve gender equity in academic rheumatology

Updated EULAR recommendations for children with pedAIIRD

Updated EULAR recommendations for children with pedAIIRD

Startup receives federal grant for developing technology to detect and treat stress, anxiety

Startup receives federal grant for developing technology to detect and treat stress, anxiety

First anti-SARS Cov2 monoclonal antibody candidate of SpikImm demonstrates excellent tolerance

First anti-SARS Cov2 monoclonal antibody candidate of SpikImm demonstrates excellent tolerance

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

E-cigarette use alters respiration but does not impair lung function, according to new findings

E-cigarette use alters respiration but does not impair lung function, according to new findings

Scientists computationally restore the potency of an antibody against SARS-CoV-2 Omicron subvariants

Scientists computationally restore the potency of an antibody against SARS-CoV-2 Omicron subvariants

Combination of multi-specificity and antibody avidity enhances protection against SARS-CoV-2

Combination of multi-specificity and antibody avidity enhances protection against SARS-CoV-2

An unprecedented list of health-threatening fungi released by the WHO

An unprecedented list of health-threatening fungi released by the WHO

UC San Diego participates in national trial to assess potential treatment for human monkeypox

UC San Diego participates in national trial to assess potential treatment for human monkeypox

Study shows potential for eliminating surgery in a small subset of breast cancer patients

Study shows potential for eliminating surgery in a small subset of breast cancer patients

Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants

Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants

Monoclonal antibodies generated from COVID-19-recovered individuals shed light on the molecular basis of SARS-CoV-2 Omicron variant immune evasion

Monoclonal antibodies generated from COVID-19-recovered individuals shed light on the molecular basis of SARS-CoV-2 Omicron variant immune evasion

Some healthcare workers vaccinated against COVID-19 show unexpectedly low responses to immunizations

Some healthcare workers vaccinated against COVID-19 show unexpectedly low responses to immunizations

Early temperamental and neurocognitive risk factors may play a role in future anxiety, depression

Early temperamental and neurocognitive risk factors may play a role in future anxiety, depression

Using magnetic bacteria to fight cancerous tumors

Using magnetic bacteria to fight cancerous tumors

What is the efficacy of RT-PCR assays for detection of SARS-CoV-2 in human semen?

What is the efficacy of RT-PCR assays for detection of SARS-CoV-2 in human semen?

What is the association of self-reported post-vaccination symptoms with anti–SARS-CoV-2 antibody response?

What is the association of self-reported post-vaccination symptoms with anti–SARS-CoV-2 antibody response?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.